- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IIIA Lung Small Cell Carcinoma AJCC v7 in Austria
Total 604 results
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Boehringer IngelheimCompleted
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompleted
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
Ascentage Pharma Group Inc.TerminatedSmall Cell Lung CancerUnited States, Australia
-
European Organisation for Research and Treatment...CompletedLung CancerFrance, Spain, Denmark, Italy, Austria, Germany
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
AmgenRecruitingMTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid TumorsUnited States, Australia, Canada
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
Syndax PharmaceuticalsCompletedCarcinoma, Non-Small Cell Lung | Non-Small-Cell Lung CarcinomaUnited States
-
NeoTX Therapeutics Ltd.Translational Drug DevelopmentCompleted
-
Trans Tasman Radiation Oncology GroupCompletedMetastatic Non Small Cell Lung CancerSingapore, Australia
-
Mologen AGCompletedSmall Cell Lung CancerBelgium, Spain, Austria, Germany
-
AstraZenecaCompletedNon-Small-Cell Lung CarcinomaCzech Republic, Italy, Korea, Republic of, South Africa, United Kingdom, Germany, Australia, Taiwan, France, Brazil
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small Cell LungChina, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
-
Arbeitsgemeinschaft medikamentoese TumortherapieSanofi; Roche Pharma AGCompleted
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
Hoffmann-La RocheActive, not recruitingNon-Small-Cell LungUnited States, Korea, Republic of, United Kingdom, Australia, France, Italy, Spain, Japan, Brazil, China, Germany, Poland, Thailand, Israel, Switzerland, Taiwan, Austria, Russian Federation, Ukraine, Hungary, Serbia, Slovenia, South... and more
-
EMD SeronoCompletedLung Cancer | Non Small Cell Lung CarcinomaUnited States, Germany, Austria
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerAustralia
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
BeiGeneTerminatedNon-Small Cell Lung Cancer (NSCLC)China, Australia
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerGermany, Austria, France
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Malaysia, Argentina, Hong... and more
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Bristol-Myers SquibbExelixisCompletedSmall Cell Lung CarcinomaUnited States, Canada, Australia, France, Ireland
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation